MA52857A - Formulations ophtalmiques à base d'atropine - Google Patents
Formulations ophtalmiques à base d'atropineInfo
- Publication number
- MA52857A MA52857A MA052857A MA52857A MA52857A MA 52857 A MA52857 A MA 52857A MA 052857 A MA052857 A MA 052857A MA 52857 A MA52857 A MA 52857A MA 52857 A MA52857 A MA 52857A
- Authority
- MA
- Morocco
- Prior art keywords
- atropine
- ophthalmic formulations
- based ophthalmic
- formulations
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19160293.7A EP3701938B8 (fr) | 2019-03-01 | 2019-03-01 | Formulations ophtalmiques à base d'atropine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52857A true MA52857A (fr) | 2021-04-21 |
Family
ID=65903880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052857A MA52857A (fr) | 2019-03-01 | 2019-03-01 | Formulations ophtalmiques à base d'atropine |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3701938B8 (fr) |
| MA (1) | MA52857A (fr) |
| PT (1) | PT3701938T (fr) |
| WO (1) | WO2020178689A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114588110B (zh) * | 2022-03-25 | 2023-08-04 | 山西利普达医药科技有限公司 | 一种眼用药物乳剂组合物及其制备方法和应用 |
| JP7884090B2 (ja) * | 2022-09-11 | 2026-07-02 | アルコン インク. | ベンジルアトロピンを含む水性医薬組成物及びその使用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2493641T3 (es) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Administración nasal de soluciones acuosas de corticosteroides |
| US9421199B2 (en) | 2014-06-24 | 2016-08-23 | Sydnexis, Inc. | Ophthalmic composition |
| US20210267885A1 (en) | 2016-05-25 | 2021-09-02 | Singapore Health Services Ptel Ltd | Atropine-containing aqueous composition |
| JP6789713B2 (ja) | 2016-08-01 | 2020-11-25 | キヤノン株式会社 | 画像形成装置及び制御方法 |
| CN108338969A (zh) * | 2018-02-08 | 2018-07-31 | 胡敏 | 一种低浓度托烷类药物滴眼液及其制备方法 |
-
2019
- 2019-03-01 MA MA052857A patent/MA52857A/fr unknown
- 2019-03-01 EP EP19160293.7A patent/EP3701938B8/fr active Active
- 2019-03-01 PT PT191602937T patent/PT3701938T/pt unknown
-
2020
- 2020-02-28 WO PCT/IB2020/051718 patent/WO2020178689A1/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP3701938A1 (fr) | 2020-09-02 |
| EP3701938B1 (fr) | 2023-11-15 |
| WO2020178689A1 (fr) | 2020-09-10 |
| PT3701938T (pt) | 2024-01-31 |
| EP3701938B8 (fr) | 2024-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3775202A4 (fr) | Agents thérapeutiques à base d'acides nucléiques | |
| EP3746090A4 (fr) | Vaccins à base d'arn contre le vrs | |
| EP3926701A4 (fr) | Panneau d'affichage | |
| EP3819300A4 (fr) | Composition thérapeutique à base de biomarqueurs | |
| EP3703672A4 (fr) | Formulations à base de cannabinoïdes | |
| EP3532240A4 (fr) | Base d'outillage | |
| MA52662A (fr) | Conjugués d'il-2 | |
| EP3995553A4 (fr) | Adhésif à base d'isocyanate | |
| EP3919581A4 (fr) | Composition d'agent adhésif à base d'uréthane | |
| EP3993782A4 (fr) | Compositions d'endoxifène à libération prolongée | |
| EP3787641A4 (fr) | Nettoyants de paupière à base d'acide hypochloreux | |
| EP3683285A4 (fr) | Composition adhésive à base d'uréthane | |
| EP3919579A4 (fr) | Composition adhésive à base d'uréthane | |
| IL285674A (en) | Pharmaceutical formulations | |
| EP3735987A4 (fr) | Conjugué d'anticorps à base d'amanitine | |
| EP3986415A4 (fr) | Formulations d'ibogaïne | |
| EP3972610A4 (fr) | Thérapie à base de mini-gènes | |
| EP3982415A4 (fr) | Panneau d'affichage | |
| EP4030778A4 (fr) | Casque d'écoute | |
| EP3820980A4 (fr) | Compositions d'esterquats | |
| EP3963137A4 (fr) | Coussinet d'appui | |
| IL286663A (en) | Hydrogel | |
| EP4020945A4 (fr) | Terminal d'affichage | |
| EP3773574A4 (fr) | Formulations d'amlodipine | |
| EP3525772A4 (fr) | Formulations destinées à l'administration entérique d'agents thérapeutiques |